Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer.
about
Prostaglandin E3 metabolism and cancerMutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathyExpression of Prostaglandin E2 Enzymes in the Synovium of Arthralgia Patients at Risk of Developing Rheumatoid Arthritis and in Early Arthritis Patients15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancerDual blockade of the EGFR and COX-2 pathways: a phase II trial of cetuximab and celecoxib in patients with chemotherapy refractory metastatic colorectal cancer.Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction.Associations between glucosamine and chondroitin supplement use and biomarkers of systemic inflammationUrinary eicosanoid metabolites in HIV-infected women with central obesity switching to raltegravir: an analysis from the women, integrase, and fat accumulation trial.PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells.Urinary PGE-M levels are associated with risk of colorectal adenomas and chemopreventive response to anti-inflammatory drugs.Intra-person variation of urinary biomarkers of oxidative stress and inflammationTargeting the eicosanoid pathway in non-small-cell lung cancer.Role of inflammation and inflammatory mediators in colorectal cancerInactivating mutation in the prostaglandin transporter gene, SLCO2A1, associated with familial digital clubbing, colon neoplasia, and NSAID resistance.Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal cancer cells.A review of the application of inflammatory biomarkers in epidemiologic cancer research.Urinary PGE-M in colorectal cancer: predicting more than risk?Biomarkers for personalizing omega-3 fatty acid dosing.Calcium intake and ion transporter genetic polymorphisms interact in human colorectal neoplasia risk in a 2-phase study.Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer.Urinary prostaglandin E2 metabolite and breast cancer risk.Regulation of cytokine-induced prostanoid and nitric oxide synthesis by extracellular signal–regulated kinase 1/2 in lung epithelial cells.Urinary prostaglandin E2 metabolite and pancreatic cancer risk: case-control study in urban ShanghaiVariants of gene for microsomal prostaglandin E2 synthase show association with disease and severe inflammation in rheumatoid arthritis.The effect of HIV and HPV coinfection on cervical COX-2 expression and systemic prostaglandin E2 levelsUrinary prostaglandin E2 metabolite and risk for colorectal adenoma.Dietary intake of PUFAs and colorectal polyp risk.Effects of celecoxib on prostanoid biosynthesis and circulating angiogenesis proteins in familial adenomatous polyposis.Supplementation of arachidonic acid-enriched oil increases arachidonic acid contents in plasma phospholipids, but does not increase their metabolites and clinical parameters in Japanese healthy elderly individuals: a randomized controlled study.A simple and robust UPLC-SRM/MS method to quantify urinary eicosanoidsLevels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers.PPARδ and PGE2 signaling pathways communicate and connect inflammation to colorectal cancerElevation of prostaglandin E2 in lung cancer patients with digital clubbingDoes Inflammation Mediate the Obesity and BPH Relationship? An Epidemiologic Analysis of Body Composition and Inflammatory Markers in Blood, Urine, and Prostate Tissue, and the Relationship with Prostate Enlargement and Lower Urinary Tract Symptoms.The omega-3 polyunsaturated fatty acid eicosapentaenoic acid inhibits mouse MC-26 colorectal cancer cell liver metastasis via inhibition of PGE2-dependent cell motility.Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS).Urine Eicosanoids in the Metabolic Abnormalities, Telmisartan, and HIV Infection (MATH) Trial.Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus.An improved LC-MS/MS method for the quantification of prostaglandins E(2) and D(2) production in biological fluids.Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts.
P2860
Q27001273-F3ACF855-989E-49E3-8067-1471E3CF9A52Q28281228-B9621A90-DD49-4B35-827D-D9A42BE6C065Q28546899-32E0D768-B356-49DE-B75C-ADD852764EDCQ28592082-9286EC15-4969-45A9-A2AC-D2CAFAD368A3Q30423537-A061C7C7-ECC9-4051-936F-631AE3793C57Q30481799-59D2B48E-558F-4B53-A149-C073E072C770Q33724542-ED3D5D99-6766-40A6-B459-CA6F9FE199F0Q33759853-C0E79E16-FAB3-4610-9C6F-0FBEF198E079Q33761715-73E7D2AF-681C-4C17-906C-08FB60426B1FQ33857191-90D35AD9-E266-4DB2-99A9-F3E42779CEE9Q33866985-11D30C18-DF82-452C-909F-1C626F444AB1Q33936807-A95AB6E2-37AE-4A6C-876F-B3BA36B28A57Q33957824-74CE8C43-6728-4430-AA84-DAC51C679415Q34017114-A0BFE539-F3BA-43C1-8692-E1053305A199Q34041309-523AAFD8-4674-417F-8E3F-24A94BCA23E2Q34135803-F558F265-18BD-4458-8D35-BE69D2AD9747Q34289285-69F3264E-97DC-48DD-9F4A-9DD97042803AQ34289313-61C93C94-D44B-4F39-9EE7-7BA90A496153Q34330801-0001AA82-6C63-4D3C-AAA5-0E99E890D7D6Q34381481-7148ABAB-B241-45E6-80A1-FEDFD248A91BQ34641787-5574FE6F-5BB8-485D-8EA2-87F9501AA820Q34881610-FD220FB8-9618-4105-A704-EAF68490F21BQ35094999-9261BB66-BD29-4AC7-8C1D-9D95FEB4B8B1Q35212728-E0841F0E-DADE-4B77-A8E9-FF053926DDDFQ35655923-5815AEB0-0933-4504-862C-78BEC6EE95B5Q35740134-8042A3A6-8A89-4B88-9886-0B61BBC7D5ADQ35753127-9F322E90-809B-4AD3-9599-91577CCF1ECDQ35847666-F5849D8A-8CCD-4306-9158-4EE821878925Q35858436-E0F5FD2A-771E-4F88-8A75-9113D77A1B2BQ35897007-6D0EF86C-E7F9-47BE-8B1B-F66527035902Q35924777-64D8F54F-0BF3-4402-B819-DFED7775990AQ35963300-D66B03E1-C887-4AA0-99B1-3B0F324FDCF4Q36019812-26C1DFCE-28E0-4C83-8EED-07C5DFCFFE98Q36059979-FA64D513-626A-4B2F-BF52-5D31198261F1Q36166684-4980323E-F30F-4F02-81A4-D71D42B77D89Q36248969-20FA0A32-CA61-405B-8A50-7C798539C43CQ36258777-C334191F-6158-4B60-BF7A-22728AB9FA7BQ36349535-9BE01A73-EAAE-42CD-A3D6-5481A6BA89A7Q36512876-6EB7F198-CA99-45DD-AB72-94AACC092EFEQ36594073-8C450F26-1FC3-40AF-B8EE-658D49F8D9CC
P2860
Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Quantification of the major ur ...... ns and those with lung cancer.
@en
Quantification of the major ur ...... ns and those with lung cancer.
@nl
type
label
Quantification of the major ur ...... ns and those with lung cancer.
@en
Quantification of the major ur ...... ns and those with lung cancer.
@nl
prefLabel
Quantification of the major ur ...... ns and those with lung cancer.
@en
Quantification of the major ur ...... ns and those with lung cancer.
@nl
P2093
P356
P1476
Quantification of the major ur ...... ns and those with lung cancer.
@en
P2093
David H Johnson
Ildiko Csiki
Jason D Morrow
John A Oates
Laine J Murphey
Loretta M Byrne
Myles K Williams
Stephanie C Sanchez
P304
P356
10.1016/J.AB.2004.08.019
P407
P577
2004-11-01T00:00:00Z